1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: 
Outcome
Pressure Gradient across Stenosis Transverse Sinus Stented (Left, Right, None) Duration of Follow-Up (mo) Time to Significant Improvement of Symptoms (mo) Headache^a Papilledema^a: Frisén (0–5) Visual Acuity^a
Before (mm Hg) After (mm Hg) Left Right
1 >10 Not recorded Right 32 1.5 Improved 1 20/30 20/40
2 >10 Not recorded Left 60 1.5 Improved 1 20/20 20/20
3 5 n/a None 18 4 Improved 1 20/20 20/20
4 30 5 Right 19 0.5 Improved 0 20/25 20/20
5 50 23 Right 12 Immediate Improved 1 20/20 20/20
6 16 5 Right 5 Immediate Improved 1 20/25 20/25
7 36 12 Right 7 Immediate Resolved 0 20/25 20/20
8 28 14 Right 4 Immediate Resolved 1 20/20 20/20
9 11 2 Right 13 0.5 Improved 0 20/20 20/20
10 40 19 Right 6 1.5 Improved 0 (atrophy) 20/25 20/150
11 5 n/a None 3 3 Improved 0 20/25 20/20
12 15 10 Left 43 0.5 Improved 0 20/25 20/25
13 8 n/a None 8 Immediate^b Improved^b 1^b 20/40 20/40


a Headache, papilledema, and visual acuity assessed at 6 mo or at the time of longest follow-up.


b Symptoms and papilledema improved on 2 g daily diamox, and headache further improved after ventriculoperitoneal shunt placement.